Search Results

• • 3 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes

  Authors:Nick Freemantle, Lawrence Blonde, Didier Duhot, Marcus Hompesch, Robert Eggertsen, F.D. Richard Hobbs, et al.From:Diabetes Care (Vol. 28, Issue 2) Peer-Reviewed

  Feb. 20051,375 words Article Inhaled insulin (INH, Exubera) is under investigation for preprandial treatment of patients with type 1 and type 2 diabetes (1-3). This dry-powder insulin formulation is delivered by aerosol, permitting the noninvasive...

• Efficacy of Sulbactam/Ampicillin or Clindamycin in the Treatment of Foot Infection in Patients with Diabetic Polyneuropathy

  Authors:KONRAD MEYNE, ELMAR STRIDDE, BRIGITTE KLUTH-PEPPER, and DAN ZIEGLERFrom:Diabetes (Vol. 49, Issue 5) Peer-Reviewed

  May 2000233 words Abstract, Brief arti... Factors such as polyneuropathy, peripheral vascular disease, renal impairment or polymicrobial infection can make treatment of foot infection difficult. In an open, randomized trial Sulbactam/Ampicillin (SBT 1g/AMP 2g...

• Development and validation of a new measure to evaluate psychological resistance to insulin treatment

  Authors:Frank Petrak, Elmar Stridde, Friedhelm Leverkus, Alexander A. Crispin, Thomas Forst, and Andreas PfutznerFrom:Diabetes Care (Vol. 30, Issue 9) Peer-Reviewed

  Sept. 20073,796 words Clinical report 1460LOBJECTIVE--To develop a psychometric questionnaire to measure psychological barriers to insulin treatment in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS--Scale development was based on principal...